fetoprotein
foetoprotein
passive immunity
oncofetal
lucatumumab
antioncogene
arcitumomab
oncoimmunology
ozogamicin
acquired immunity
polyantigenic
affitin
BRCA
panitumumab
naptumomab estafenatox
antihuman
pappalysin
cancerome
precipitin
hepatoblast
immunoediting
drozitumab
immunologically
fetopathy
patritumab
apolizumab
immunoscoring
onartuzumab
antigenic
antinucleotide
avelumab
dacetuzumab
countercorrelated
specific
erythroblastosis fetalis
antimaternal
agglutin
wombling
antimouse
intetumumab
radioimmunoreactivity
-tum-
embryocarcinoma
oncopeptide
idiospecific
-got-
mapatumumab
microlymphocytotoxicity
immunocytic
teprotumumab
intrabody
muromonab
alloantigen
figitumumab
inotuzumab ozogamicin
immunogenetic
carcinoembryonic
polyvalent
immunologic
samalizumab
antisubstance
paratope
matuzumab
heteroclitic
lintuzumab
immunocarrier
oleclumab
ertumaxomab
iratumumab
conatumumab
pancytokeratin
ABO antibodies
endokinin
antiantibody
polyantibody
glembatumumab
multiantigen
antimonoclonal
antiserum
catumaxomab
immunoblastic
polytypic
homophilic
immunocytologically
panhypogammaglobulinemia
anticorrelate
nofetumomab
tigatuzumab
immunofactor
heteroimmune
immunoserological
lexatumumab
immunospecific
affibody
lenzilumab
amlitelimab
immunoprofile
immunostatus
oncofetal
polyantigenic
antihuman
antigenic
countercorrelated
specific
antimaternal
antimouse
idiospecific
immunocytic
immunogenetic
carcinoembryonic
polyvalent
immunologic
heteroclitic
multiantigen
antimonoclonal
immunoblastic
polytypic
homophilic
heteroimmune
immunoserological
immunospecific
immunologically
immunocytologically
fetoprotein
foetoprotein
passive immunity
lucatumumab
antioncogene
arcitumomab
oncoimmunology
ozogamicin
acquired immunity
affitin
BRCA
panitumumab
naptumomab estafenatox
pappalysin
cancerome
precipitin
hepatoblast
immunoediting
drozitumab
fetopathy
patritumab
apolizumab
immunoscoring
onartuzumab
antinucleotide
avelumab
dacetuzumab
erythroblastosis fetalis
agglutin
wombling
intetumumab
radioimmunoreactivity
embryocarcinoma
oncopeptide
mapatumumab
microlymphocytotoxicity
teprotumumab
intrabody
muromonab
alloantigen
figitumumab
inotuzumab ozogamicin
samalizumab
antisubstance
paratope
matuzumab
lintuzumab
immunocarrier
oleclumab
ertumaxomab
iratumumab
conatumumab
pancytokeratin
ABO antibodies
endokinin
antiantibody
polyantibody
glembatumumab
antiserum
catumaxomab
panhypogammaglobulinemia
nofetumomab
tigatuzumab
immunofactor
lexatumumab
affibody
lenzilumab
amlitelimab
immunoprofile
immunostatus
anticorrelate
English words for 'any of several antigens that occur naturally in the fetus and sometimes in adults with cancer'
As you may have noticed, above you will find words for "any of several antigens that occur naturally in the fetus and sometimes in adults with cancer". Hover the mouse over the word you'd like to know more about to view its definition. Click 
to find a better fitting word. Finally, thanks to ChatGPT, the overall results have been greatly improved.
Recent Queries
parasitic disease
tendonitis
superb view
shrubbery
to infect
beauty contest
(at) one's own expense
smog
trainspotter
surface.
quibbler
house name
daimyō
Inappropriate
simulcast
new theory
components
paper tray
far-off
phase transformation
them
intercellular
entangle.
uncountable noun
treatment plant
ornamental
caucus
trivial.
legless.
skyrocketing
without hardship
VIP
Electric
amply
To try
outside of.
Downright
for dear life
To throw out
bestow
pork.
emissary
clang
midway
fashionable.
concentration
artist
vacantly
filthy
mood